LRQA, the world’s leading provider of professional assurance services, attended the annual Life Sciences College (LSC), an innovative and widely-attended global conference series launched by U.S. law firm Sidley Austin LLP in 2012.
To be aptly held in Brussels on 19 May, often thought of as the heart of EU medical devices legislations, this year’s conference addressed the topic of “Recent Developments in EU Pharmaceutical and Medical Device Law”, and featured prominent speakers from healthcare and competition regulators, including from the European Commission, European Data Protection Supervisor, national authorities and representatives from the pharmaceutical industry.
Theresa Jeary, LRQA Technical Manager for Medical Devices Directives (MDD), said, “LRQA has witnessed and participated in the growth and evolution of the medical devices regulatory sector over its more than 20-year history as a leading Notified Body. This panel alongside other senior legal professionals in the life sciences and pharmaceutical arenas are a good platform for us to learn from and contribute further to the ongoing discussion around changing medical devices regulations.”
The medical regulatory landscape is undergoing its most significant overhaul in years, and with that comes a need to stay up-to-date with the latest regulatory intelligence and how the changes impact organisations serving the medical arena worldwide. To support companies in managing their transition to the revised ISO 13485:2016, LRQA recently launched a series of ISO 13485:2016 training courses following the standard’s publication this month.
For more information on how LRQA’s range of assessment and training services can help, please visit www.lrqamea.com or email email@example.com.